Objective: To assess the efficacy and safety profile of docetaxel, as a single agent, in the treatment of elderly patients with advanced breast cancer. Methods: Twenty-eight patients, with a ...

Both were in patients receiving docetaxel at the 100 mg/m 2 dose ... The median of the 14 patients who responded to treatment was 14.4 months (95% CI 6.0, 22.7). The median time to disease ...

The treatment landscape for patients with prostate cancer, especially individuals with advanced disease, has dramatically ...

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

When should Docetaxel not be taken ... Monitor liver blood function and blood counts regularly. Treatment with corticosteroids before starting this medication is recommended.

The first treatment of its kind for metastatic NSCLC, Optune Lua is approved for use concurrently with PD-1/PD-L1 inhibitors or docetaxel in adult patients with metastatic NSCLC who progressed on ...

or docetaxel in adult patients with metastatic non-small cell lung cancer (mNSCLC), has received approval from the US FDA. Approved on the basis of positive Phase III data, the treatment is aimed ...

ONCOLife proudly presents an exclusive interview with Dr. Iris Kuss, VP and Global Development Lead Oncology at Bayer. In ...